CEO Archives - Green Market Report

Debra BorchardtJanuary 19, 2022


The Canadian Center For Policy Alternatives recently released a report titled “Another Year In Paradise – CEO Pay in 2020. The report lists a couple of cannabis company CEOs with what it determined to be outsized compensation packages. The report stated, “Canada’s 100 highest-paid CEOs got paid an average of $10.9 million in 2020, which is higher than their pay in 2019. As a result, those 100 CEOs now make, on average, 191 times more than the average worker wage in Canada.” The report also stated that variable compensation, which can be bonuses, company stock, or options rose from roughly 70% a decade ago to over 80% in the past two years. Now it seems salaries have become a less important part of CEOs’ total compensation.

The report also delved into the support many businesses received during the pandemic. It pointed out that substantial government support flowed to companies headed by some of the highest-paid CEOs in the country. 

Leading the list on the report was David Klein, CEO of Canopy Growth Corp (NASDAQ: CGC) who is listed as having a salary of C$281,715 share-based awards of C$10,075,349, option-based awards of C$33,267,017, non-equity incentive compensation of C$408,739, other compensation listed as 1,273,265 for a grand total of C$45,306,085. 

Ranking at 18 on the list Kurt Schmidt, President & CEO of  Cronos Group Inc. (NASDAQ: CRON) having a salary of C$195,859 share-based awards of C$3,187,404 option-based awards of C$9,859,488 non-equity incentive compensation C$326,811 for a total of C$13,569,562. 

Tilray (NASDAQ: TLRY)  wasn’t listed in the report, but CEO Irwin Simon has a base salary of $1.7 million according to the company’s filings. In addition, the Tilray Compensation Committee in July 2021 awarded Mr. Simon a one-time cash retention bonus of $10 million. Mr. Simon was granted 392,772 PSUs which are performance-restricted stock units. On July 27, 2021, Simon received a one-time equity grant having an aggregate value equal to $15 million. For the fiscal year 2021, the Compensation Committee determined Mr. Simon’s cash bonus to be $3,185,000, which was paid to him on August 15, 2021. This easily puts him ahead of Schmidt on the list. Tilray said the CEO ratio of pay to the average employee is 13 to 1. 

So while Simon’s total compensation may be lower than Klein’s, the inclusion of those one-time bonuses and the generous regular salary might be more lucrative.

Cannabis C-Suite

In May 2021, the CannaBiz Team released a report that stated C-suite executives in the cannabis business saw double-digit salary increases in 2021 compared with 2020. The report determined that a cannabis company’s chief executive officer’s salary rose to a median of $350,300 in 2021, up 11% from a median of $314,450 in 2020. For a chief financial officer, the median salary climbed 10% to $348,500 from $318,000 in 2020. MJ Biz looked at U.S. cannabis company CEO pay in July 2021 and found that Cresco CEO Charlie Bachtell was the highest-paid CEO of an American MSO with 2020 compensation valued at $4.5 million. Bachtell was paid a salary of $450,000 and was paid a bonus of $87,500, according to a regulatory filing. Looks relatively meager by comparison to his Canadian counterparts. 

Debra BorchardtMay 6, 2020


CEO Stormy Simon is out at Hightimes Holding Corp. after just four months. Former Green Growth Brands (OTC: GGBXF) Peter Horvath is in. This is the third CEO for the iconic publisher High Times in just 13 months as the company pivots away from events and news and instead heads towards the dispensary side of the industry.

“We are pleased to welcome Peter to the High Times family, and to be able to tap into his wealth of experience capitalizing on major consumer brands. There are few executives with his retail experience in the mainstream world and, up to this point, none in the cannabis world with such an accomplished background,” Hightimes Holding Corp. Executive Chairman Adam Levin said. “The team and I would like to thank Stormy for all of her hard work in getting us through this transition period, and we are excited to have her continue working with us on this mission to grow High Times into all the business areas it helped create.”

Horvath’s Track Record

The High Times press release notes that Horvath previously held leadership roles for companies such as L Brands (Victoria’s Secret, Bath & Body Works, etc. ), American Eagle Outfitters (American Eagle & Aerie), and DSW (Designer Shoe Warehouse) and that he was with DSW when it went public on the NYSE in 2005. It also mentioned that he formed Green Growth Brands and took it public on the CSE in November 2018. It even touts his launch of Seventh Sense CBD. What it doesn’t mention is that Horvath was forced to resign recently and left without his million-dollar severance package after the company burned millions of dollars on Seventh Sense. The chain was closed in March and attempted to not pay the laid-off employees their back pay until Green Market Report exposed the story. 

“High Times is a unique brand with an important and rich heritage that deserves amplification and broader reach,” stated incoming Chief Executive Officer Peter Horvath. “I think of brands like Glossier, who first earned high affinity followers through compelling and relevant content, and then demonstrated that you can also serve their followers through commerce.  So, it’s been done before, I wouldn’t suggest that it will be easy, but we have all the resources to succeed.”

Victoria’s Secret is also about to go under. The once-thriving leader in women’s lingerie miscalculated its customer base’s move away from the over-sexualization of women. As women were moving away from body shaming and embracing all shapes and sizes, Victoria’s Secret was slow to recognize the seismic shift, and competitors began to take market share. The company recently tried to sell itself to a private equity firm, but the sale has fallen through. With retail in a tailspin due to the COVID-19 lockdown, it’s future is unclear.

CEO Revolving Door

It’s highly unusual for companies planning to go public to have a revolving door of CEO’s. A potential publicly-traded company typically wants to project an image of stability in order to show shareholders that their investment is in good hands. The Horvath hire is meant to align with High Times’ recent acquisition of pending and operational licenses from  Harvest Health & Recreation (OTC:HARV). His retail background seems more suitable to chairman Adam Levine’s vision for High Times dispensaries versus the previous CEO Stormy Simon.

Simon was just hired in January with her previous experience at e-commerce brand as the reason she moved from her position as a board member to the role of CEO. At the time of her hire, High Times said it was creating a virtual distribution business alongside its physical businesses of dispensaries and consumption cafes. The company signaled that Simon wasn’t necessarily in charge as the recent announcement with Harvest Health did not include her whatsoever. It’s highly unusual for a company CEO to not be quoted in an acquisition press release or be included in the purchase documentation. Her absence sent red flags that something was underway. It’s unclear whether Simon remains on the board. She is currently running for state representative in Utah.

Levine stepped down from the CEO role when Kraig Fox stepped in to lead the company through its efforts to go public and shift towards a plant-touching business. Fox was hired in April 2019 and left nine months later.  Fox’s background as a Senior Managing Director of Guggenheim Partners where he focused on Guggenheim’s overall strategy in the media and entertainment spaces as well as the management of its media and entertainment investments was seen as an asset.

Fox continues to receive his director and officer insurance policy, and High Times agreed to reimburse Fox for certain previously incurred business expenses (within five days) of successful completion of sales of an additional $5 million of equity securities or $10 million of proceeds from the sale of debt securities. He is expected to be reimbursed $125,000 with respect to expenses and lease payments for which Fox provided the company with receipts.

Harvest Health Deal

High Times did acknowledge that its deal to acquire the licenses from Harvest Health was subject to certain closing conditions, including the receipt of certain regulatory and third-party consents. The parties are aiming to close the acquisitions no later than June 30, 2020, subject to the parties’ mutual agreement to extend the closing date.

There is a major problem with one of the Have A Heart dispensaries that High Times is buying from Harvest Health. One license belongs to the HAH San Francisco location in which CEO Alexis Bronson says Harvest Health had no right to sell. Bronson owns 40% of the HAH dispensary and he claims his business partners sold their shares to Interurban Capital Group (ICG) without his approval. The dispensary was then flipped to Harvest Health & Recreation, who just sold it to HHI Acquisition Corp, a subsidiary of Hightimes Holding Corp.

The High Times Purchase Agreement acknowledges the Bronson position in HAH. The document states, “Neither ICG nor Harvest holds any rights to acquire the 40% interest held by Bronson. Assignment of Contingent Assignment requires the consent of the Board of Managers of HAH 2 CA LLC.” High Times was to deliver $1 million to Harvest Health on April 27 as a deposit and then another $4 million at the closing date or within 45 days of the effective date. High Times did not respond to a request to comment on the Bronson situation. Harvest is also suing ICG which adds even more complications to this deal.

The issue with this one particular license may not hold up the whole deal and if High Times can close at least some of the operational licenses then revenue can begin flowing into the company.

Delayed Reporting

High Times announced that it will delay delivering its annual report as per the SEC’s order which allows for this due to the COVID-19 virus.

Debra BorchardtOctober 2, 2017


How is it that a man who knew little about marijuana ended up being the CEO of one of the largest privately held cannabis companies in the country?

Ralph Morgan is the current Chief Executive Officer of O.penVAPE, which is the largest branch of Organa Brands. He started his career in healthcare, but as he was climbing the corporate ladder he felt he was moving further away from healthcare.

I started a dispensary in 2009 with my wife because I knew how to speak to people with ailments and basically that was it,” he said. “I had very little experience with cannabis.” His research into the product told him it was the perfect place for entrepreneurial opportunity. “It’s controversial, a little bit of David and Goliath, a little bit of right and wrong. Great opportunity on the upside for a social change.”

His experience as a dispensary owner, however, showed him that there was a gap in the market for products that were consistent, reliable and safe. This encouraged him and his wife to invest in a MIP or manufactured infused product facility and this was the birth of Organa Labs in 2010.

He invested in CO2 equipment. “It was avant-garde at the time,” said Morgan. Then e-cigarettes started taking off and he started playing around that concept. By 2012, Morgan and his partners had decided that vaporizers were the ideal way to consume cannabis. They felt it was going to be a disruptive technology for the cannabis market and they were right. O.penVAPE was born and the company has grown into a business that does over $100 million in sales each year.

The challenge the company faces now is scaling and growing. Morgan said that picking great partners comes from surviving bad partnerships. “At this size, the stakes are just that much higher. A new partnership means we have to get it right, if we get it wrong, can we recover?” he asked. “Each mistake gets more expensive. We made a lot early on, but the costs were low.”

Morgan’s time as CEO is about to shift. “I started as CEO of Organa Labs, but I don’t act in that capacity anymore and I’ll officially change that to President of Wellness and CBD products,” he said. The company is planning on expanding the leadership to people outside of the cannabis industry. Morgan said they are looking for folks that have the experience to grow a company that’s on track to be a billion company in a few short years. “I’ve never done that before,” he said. “Despite my tenacity, I’m not qualified. We need better help. We’ve got one chance to get this right.”

Now he is focusing on the medical vertical and wellness line as he gets back to his roots. “It’s something that is near and dear to my heart.” We should have a full launch by Christmas of this year. It will be called OBA, Organa Brands Alternatives.”

With Organa Brands, it will be healthier alternatives to conventional products. Instead of a 5-hour energy drink like a Red Bull, OBA will have an energy option with CBD in it. Some will have THC in them, but the products without THC will be sold everywhere.

The OBA will have several categories, but none including vapes since that’s already available. There will be pressed pills for energy, sleep, relax and rejuvenation. A gel cap product called “Daily Dose” with a small amount of THC or CBD. A point of purchase kiosk is designed to educate the customer. It has a simple decision tree to help drill down into the product. There will be hard copy, plus a tablet to give information.

Morgan said the culture of Organa is hiring someone with the right attitude, passion and moral compass. “We work way too hard for this to be just a job,” he pointed out. “If you’re just here to make a buck you’re in the wrong industry.” Some of Organa’s company perks include free rides on Uber, matching the 401k two to one and generous pay. Morgan said, “If you have the right attitude, there’s a seat on the bus for you.” He’ll be driving the bus.

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.